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Abstract
Background: Microarray technology is a powerful methodology for identifying differentially
expressed genes. However, when thousands of genes in a microarray data set are evaluated
simultaneously by fold changes and significance tests, the probability of detecting false positives
rises sharply. In this first microarray study of brachial plexus injury, we applied and compared the
performance of two recently proposed algorithms for tackling this multiple testing problem,
Significance Analysis of Microarrays (SAM) and Westfall and Young step down adjusted p values, as
well as t-statistics and Welch statistics, in specifying differential gene expression under different
biological states.
Results: Using SAM based on t statistics, we identified 73 significant genes, which fall into different
functional categories, such as cytokines / neurotrophin, myelin function and signal transduction.
Interestingly, all but one gene were down-regulated in the patients. Using Welch statistics in
conjunction with SAM, we identified an additional set of up-regulated genes, several of which are
engaged in transcription and translation regulation. In contrast, the Westfall and Young algorithm
identified only one gene using a conventional significance level of 0.05.
Conclusion: In coping with multiple testing problems, Family-wise type I error rate (FWER) and
false discovery rate (FDR) are different expressions of Type I error rates. The Westfall and Young
algorithm controls FWER. In the context of this microarray study, it is, seemingly, too conservative.
In contrast, SAM, by controlling FDR, provides a promising alternative. In this instance, genes
selected by SAM were shown to be biologically meaningful.
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Injuries to nerve or tissue cause an immediate sensation of
pain, or acute pain, which resolves with the resolution of
the injury. Less commonly, these injuries produce a heter-
ogeneous group of pathological states that produce chron-
ic pain that is unresponsive to the analgesics used to treat
acute pain. It would be therefore of great interest to map
the characteristic features of gene expression following
nerve injuries, as they may reveal mechanisms of chronic
pain and genetic targets for the design of novel therapies.
In this study we apply the powerful microarray technolo-
gy to study the injuries of the brachial plexus, a typical
form of nerve injury from motorcycle or workplace inci-
dences [1]. Since this is largely a paper focusing on meth-
odology, we refer the readers to our website [2] for details
of the brachial plexus injuries.
The goal of this study, detection of condition or state-de-
pendent differentially expressed genes, is an important
problem in the context of microarrays. Fold changes and t
tests have been applied to microarray datasets to yield lists
of genes that have undergone altered expression under a
certain significance threshold. Although these methods
are useful in identifying potential gene targets, they are
best applied to small sets of hypothesis tests. In the con-
text of microarray experiments where thousands of genes
are commonly evaluated simultaneously, the probability
of detecting false positives rises sharply. Two recently pro-
posed algorithms seeking to address this multiple testing
problem, Significance Analysis of Microarray (SAM) and
Westfall and Young step-down adjusted p values, will be
investigated in our study. We note at the outset that our
investigation of methods for detection of such differen-
tially expressed genes has several limitations. Firstly, it is
based solely on the brachial plexus injury data which, in
turn, is limited by small sample sizes (10 injured patients
and 3 controls). However, such small sample sizes are
characteristic of many current microarray studies, in view
of technologic expense, so that exploration in this setting
is purposeful. Secondly, our investigation is largely empir-
ic, there being no overarching theory by which to arbitrate
competing approaches. Nonetheless, it is the frequently
observed heteroskedasticity of gene expression measure-
ments that motivates our extension of the SAM methodol-
ogy (see below) to Welch statistics.
SAM was designed to evaluate the significance of changes
in gene expression between different biological states [3].
SAM assigns a score to each gene (here and below what we
refer to as genes are actually probe sets on the chip that
target full length cDNAs or ESTs) as an index of the rela-
tive difference between groups. A gene is labeled as signif-
icant if its score surpasses a threshold. SAM terms the
percentage of genes identified by chance the false discov-
ery rate (FDR) and estimates this quantity by recourse to
permutation. The threshold can be adjusted to identify
different sizes of sets of putatively significant genes, and
FDRs are modified accordingly. We note here that this dif-
fers from the formulation and sequential control of FDRs
as originally proposed by Benjamini and Hochberg [4];
see Storey [5] and Storey and Tibshirani [6] for discussion
of the distinctions and considerations pertinent to micro-
array data analysis. Throughout, we will use FDR in the
sense of SAM. Tusher, et al. used SAM to study the tran-
scriptional response of lymphoblastoid cells to ionizing
radiation, and they were successful in identifying 34 bio-
logically meaningful genes. A different algorithm, pro-
posed by Westfall and Young and adapted by Dudoit et
al.[7] for microarrays, tackles the multiple testing problem
from a different angle. It controls the family-wise Type I
error rate (FWER), which is the probability of having at
least one false positive among all hypotheses tested. It
provides less conservative control than the traditional
Bonferroni, Šidák, and Holm corrections and is able to
handle the dependence (e.g. co-regulation) among gene
expression profiles. In a study that tested whether altera-
tions in the expression of genes related to high-density li-
poprotein metabolism affects the expression of other
genes, multiple-testing methods identified 5 genes that
showed significant altered expression levels in scavenger
receptor BI transgenic mice and 4 genes in apolipoprotein
AI-knockout mice [8]. Further discussions, additional ap-
proaches and comparisons can be found at [9].
In the comparison of expression levels of more than 5000
probe sets between normal subjects and brachial plexus
injury patients, we adopt both SAM and Westfall & Young
algorithms using regular t statistics assuming equal vari-
ances and t statistics assuming unequal variances (hereaf-
ter called Welch statistics). The application of Welch
statistics is motivated by the work of Thomas, et al.[10]. In
their paper, they applied Welch tests on a leukemia data-
set [11] and demonstrated the importance of allowing for
unequal variances. Following a similar approach, we have
identified a set of known and novel genes that largely fall
into six categories: cytokines / neurotrophine, myelin
function, signal transduction, cytoskeleton, transcription
/ translation and others. Some genes are confirmed by lit-
erature; others still require explanation and future re-
search. We also compared the performance of SAM and
Westfall & Young algorithms, as well as t statistics and
Welch statistics. In this study, we hope to provide a frame-
work for future experimental research in avulsion injuries
and pain. In addition, we illustrated the use of appropri-
ate multiple testing methods for microarrays in monitor-
ing differential gene expression between different
biological states.Page 2 of 11
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Data displays for test statistics
Figure 1 is a scatter plot of the intensity readings for a pa-
tient (P15) and the corresponding readings of a control
(C1). The considerable deviation from the identity line in-
dicates that gene expression is substantially disturbed as a
consequence of the avulsion injury. For comparison, the
scatter plots for a pair of control and a pair of patient data
sets clearly show less deviation.
The frequency distribution of t statistics and the normal
Q-Q plot for t-statistics are provided in Figure 2. Both the
histogram and the Q-Q plot show that the distribution of
t-statistics is not normal. However, in our study we are
more interested in identifying genes with substantial t-sta-
tistics than in testing the distribution of t-statistics. The
genes having t-statistics that deviate markedly from the
bulk of the observations were labeled as potentially hav-
ing biological significance and may deserve further inves-
tigation [8]. Plots of t-statistics against average intensities
and different components of t-statistics against each other
(Figure 3) are especially useful in identifying genes with
substantial statistics and in studying the features of these
genes [7]. The average intensity for each gene is the aver-
age of the mean expression level for the patient and the
control groups. In Figure 3, large t-statistics were easily vis-
ualized and labeled in red. They correspond to the same
genes identified as outliers in the Q-Q plot (Figure 2). The
six genes that have the largest t-statistics do so by virtue of
having denominators close to zero, implying near con-
stant expression levels. Further, their expression levels are
observed to be very low. Consequently, these genes might
be of little biological interest. In order to more systemati-
cally evaluate differential expression and complement
these graphical approaches, we next apply SAM.
Application of SAM: t-SAM and Welch-SAM
t-SAM
Experimental outline
We used the SAM methodology to identify genes with sta-
tistically significant changes in expression. For the ith gene
a modified t-statistic, d(i), was used to quantitate differen-
tial expression.
All quantities here and below are defined in the Methods
section. The s0 factor was added to help ensure that the
variance of d(i) is independent of gene expression level
and to mitigate problems caused by small denominators.
A similar strategy derived from a Bayesian approach is de-
tailed in [12]. In order to select an appropriate s0 value for
this dataset, we plotted ∆ against FDR using different val-
ues of s0. Figure 4 shows that calculating s0 according to
the Tusher, et al. prescription yields a value equal to the
d i
x x
S i + S
i i
0
( ) = −( )
1 2
Figure 1
Global comparison of the differences in gene expression lev-
els between a) a patient (P15) and a normal subject (C1); b) a
pair of patients (P15 and P12); c) a pair of normal subjects
(C1 and C2).
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genes, which fails to reduce FDRs. We therefore elected to
set s0 at the 5th percentile of the pooled standard devia-
tions (s0 = 2.8); this choice does reduce FDR.
As ∆ increases, the number of significant genes decreases,
but at the same time the percentage of falsely called genes
also decreases. The curve of FDR vs. ∆ in Figure 4 shows
that FDR generally decreases monotonically as ∆ increas-
es, but from some ∆ on the decrease flattens markedly (see
also Table 1). The choice of ∆ is somewhat arbitrary, but
is driven by choosing an acceptable FDR and an appropri-
ate number of significant genes. We choose ∆ = 12, corre-
sponding to an FDR at 18%. This yields a set of 73
significant genes that are described next. Not surprisingly,
the concordance between genes identified via graphical
methods and those selected by SAM is high.
Genes identified by t-SAM
The 73 genes that are most highly ranked by t-SAM may
represent more than one interacting molecular network
and could be divided into different functional categories.
Interestingly, only one gene (Autoantigen pericentriol
material) has increased expression while the expression of
the other 72 genes is decreased in the patient group. Un-
fortunately, in the present instance samples are no longer
available and experimental verification of identified genes
awaits future studies.
Cytokines / Neurotrophines
Mild tissue damage, nerve damage and infection produce
inflammation and associated pain. This results in the mi-
gration of immune cells to the site of injury, which is fol-
lowed by release of cytokines [13]. Five genes identified as
significant by t-SAM have been reported in the literature as
relevant to the inflammation and pain pathways. Inter-
leukine 13 inhibits inflammatory cytokine production.
Midkine is associated with neurite growth and was recent-
ly discovered to have potent neuroprotective activity in
vivo [14]. IGFBP6 plays a significant role in the differenti-
ation, maintenance and regeneration of the central
cholinergic neurons[15]. Cysteine-rich fibroblast growth
factor receptor is also implicated in neuronal growth and
differentiation. TrkA plays a crucial role in the develop-
ment and function of the nociceptive reception system.
Myelin function
Three genes were identified that are involved in myelin
structure and myelination: MPZ (myelin protein zero),
PLP1 (myelin proteolipid protein 1) and MBP (myelin ba-
sic protein). Defects in these genes are the cause of demy-
elinating neuropathies.
Figure 2
Histogram and QQ plot of t-statistics calculated from the
normalized gene expression levels. Large t-statistics are
labeled in red.
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Table 1: Comparison of t-statistics and Welch statistics in identi-
fying significant genes under different values of ∆s
∆ Significant genes False positives FDR
t-statistics
2 622 312 50%
4 223 77.3 35%
6 131 35.1 27%
8 88 21.2 24%
12 73 13.3 18%
16 62 9.8 16%
20 57 7.7 14%
25 46 5.8 13%
40 30 3.4 11%
60 27 2.4 9%
90 19 1.5 8%
Welch statistics
2 1348 648.3 48%
4 525 155.9 30%
6 264 64.5 24%
8 97 24.0 25%
12 50 10.4 21%
16 20 4.0 20%
20 12 2.5 21%
25 7 1.0 14%
40 7 1.0 14%
60 6 0.4 7%
90 6 0.4 7%Page 4 of 11
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PKC and Frizzled play roles in apoptosis. The down regu-
lation of both might represent a cellular response to pre-
vent neurons from death.
Cytoskeleton
Three genes: Myosin light chain, Myosin heavy chain and
MLCK (Myosin light-chain kinase) are notable in this cat-
egory. The altered expression of them together suggests a
probable link between calcium signaling and rearrange-
ment of the cytoskeleton, possibly leading to long-term
changes in neuronal morphology.
Others
MT-III has been recently implicated as being involved in
sensory and nociceptive transmission [16]. Its down regu-
lation might also lead to promotion of neurite extension
to promote recovery in the patients.
Welch-SAM
Thomas, et al.[10] showed that in the two-group microar-
ray study setting the t-statistic assumption of equal vari-
ances between the two groups could result in poor
performance. We therefore extended the SAM framework
to include Welch statistics. Under the assumption of une-
qual variances, the associated degrees of freedom are var-
iable, and the strict monotonic decreasing relationship
between p values and test statistic values no longer holds.
Accordingly, it is misplaced to use the values of the statis-
tics under permutation. Rather, for each data permuta-
tion, we standardized the Welch statistic using an
appropriate t referent distribution and used the resultant
"p values" as described in the Method section; see also
Figure 3
Plots of t-statistics, t-numerators, t-denominators and average intensities against each other. Large t-statistics are labeled in
red.
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tween-group heterogeneity, Welch-SAM identified a set of
up regulated genes that were not detected by t-SAM. Sev-
eral of these up regulated genes are engaged in transcrip-
tion and translation regulation: transcription factor AP-4,
transcriptional coactivator Pc4, Nrf2, EIF5 (Eukaryotic
translation initiation factor 5), and PABPL1 (polyade-
nylate-binding protein 1). In addition, two genes are in-
volved in cell cycle regulation: Autoantigen pericentriol
material and CDC-like kinase. Their identification sug-
gests a secondary mechanism to repair the damaged cells.
The entire list of genes identified by t-SAM and Welch-
SAM can be found at [2].
t-SAM vs. Welch-SAM
The relationship between FDR and ∆ for Welch is also in-
cluded in Figure 4. The un-pooled variance in the denom-
inator of Welch statistic is highly unstable under
permutation in this small sample setting. Consequently,
FDR for Welch-SAM is not a smooth function of ∆, as is
the case of t-SAM. FDR values for selected ∆s for both t-
SAM and Welch-SAM when s0 was chosen at the 5th per-
centile of standard deviations, are listed in Table 1 along
with corresponding numbers of significant genes and false
positives.
Application of Westfall and Young step-down adjusted p 
values
Westfall and Young's step-down adjusted p values were
calculated using both t-statistics and Welch statistics. As
before, the Welch statistics and p values are not monoto-
nely related because of the variation in degrees of free-
dom. So, we again calibrated the Welch statistic against
the appropriate t referent distribution and determined
(unadjusted) "p values" for each permutation. The small-
est Westfall and Young adjusted p values for t and Welch
statistics were 0.053, 0.042 respectively. Figure 5 illus-
trates the relationship between adjusted p values and the
number of genes being tested. A small simulation shows
that this relationship is governed by the number of true
null hypotheses in the tests (unpublished data). Profiles
for nine selected genes are displayed; t-statistics are pre-
sented in Figure 5A and Welch-statistics in Figure 5B. For
each gene, the adjusted p value increased with the increase
of the number of null genes being tested. Genes with
smaller statistics had greater adjusted p values and their
adjusted p values increased at a greater rate when the
number of null genes being tested was larger.
Discussion
FWER vs. FDR
In a single hypothesis test, a Type I error occurs when a
true hypothesis is rejected. In multiple testing, FWER re-
fers to the probability of rejection of any true hypothesis.
When many hypotheses are tested, such as expression data
of thousands of genes being compared between different
groups, FWER increases dramatically, and is typically
much larger than the significance level at which the indi-
vidual hypotheses are tested.
As defined by Shaffer, given any test procedure, an adjust-
ed p value corresponding to the test of a single hypothesis
Hj is the level of the entire test procedure at which Hj
would just be rejected, given the values of all test statistics
involved [18]. Several approaches have been proposed to
calculate adjusted p values for the purpose of providing
control of FWER. Among these, the method developed by
Westfall and Young is best suited for microarray data anal-
ysis. It is superior to the single-step methods proposed by
Bonferroni and Šidák by allowing different p values to be
adjusted differently; therefore the power of the procedure
is improved. It is also able to take into account the de-
pendence structure between variables. In a biological sys-
tem, expression levels of groups of genes may correlate
with each other for various reasons such as co-regulation.
However, when the Westfall and Young's permutation al-
gorithm was applied to calculate step-down adjusted p
values in our dataset, only one of the adjusted p values
from Welch statistics reached a conventional significance
level of 0.05. A few factors might contribute to the absence
of adjusted p values at that significance level. First and
foremost, the small sample sizes are limiting. Further-
more, the unbalanced allocation of (10) patients and (3)
controls limits the precision of the adjusted p values. The
Figure 4
The relationship between FDR and in SAM. t-SAM is repre-
sented with three different lines with different s0 values: s0 =
0, S0 = 0.034 (the minimum of the pooled standard devia-
tions) and S0 = 2.761 (5th percentile of the pooled standard
deviations). Welch-SAM is graphed with S0 = 2.000 (5th per-
centile of the pooled standard deviations).
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The relationship between adjusted p values and number of genes tested. a) t-statistics; b) Welch statistics. Colored lines are
genes ordered by their unadjusted p values, e.g. gene1 has the smallest unadjusted p value and gene600 has the 600th smallest
unadjusted p value. c) A comparison of panel a) and b). Red lines represent the results of Welch statistics and black lines rep-
resent the results of t-statistics.
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balanced experimental design will increase the number to
1715 (13 choose 6, then minus 1). Second, the vast ma-
jority of genes are expressed at low levels, as depicted in
Figure 3, where biological signals may become indistin-
guishable from noise. For those cases where the difference
in mean expression levels is small, a pooled standard de-
viation that is also small can give rise to a significant sta-
tistic, where in fact no difference exists. Third, Figure 5
shows that adjusted p values are sensitive to the number
of null genes being tested. Given that many genes are like-
ly to be irrelevant to the biological processes underlying
the brachial plexus injuries and hence are expected to
show little difference in their expression levels between
injured patients and control subjects, it is not surprising
that no significant result was obtained for t-SAM when ap-
plying the complete data set. In Figure 5 we also try to il-
lustrate the potential abuse of using filtered gene subsets
(based on statistics measuring differential expression) to
achieve significant results, given that such filtering is com-
monplace in microarray literature. Last, although Westfall
and Young's algorithm is more powerful than Bonferroni,
Šidák, and Holm adjustments by taking into account the
joint distribution of the test statistics, it may still be too
stringent. The same result also occurred for Tusher, et
al.[3] when applying this algorithm to study the transcrip-
tional response of lymphoblastoid cells to ionizing radia-
tion. A less stringent method may therefore be needed to
analyze microaray data.
The FDR provides a different point of view on how the er-
rors in multiple testing should be controlled. Having
many hypotheses rejected signals clearly that many hy-
potheses are not true. It is therefore more crucial to con-
trol the rate of false positives among all rejected
hypotheses than the probability of one single erroneous
rejection. It might thus be argued that the control of FDR
is a more appropriate approach to dealing with the multi-
plicity concern. That argument is especially true in the set-
ting of microarray data analysis, where one is more
interested in studying as many relevant genes as possible,
and less interested in sacrificing possible targets for the
concern of making one mistake [6]. The algorithm of SAM
proposed by Tusher, et al.[3] provides an estimate of the
FDR for each value of the parameter ∆ in the application
of microarray settings. The estimated FDR is computed
from permutation of the data and allows for the possibil-
ity of dependent tests [3]. We derived a set of 73 signifi-
cant genes using SAM, out of which 13 were false
positives, giving rise to a FDR of 18%. Although SAM is
not able to disclose the identities of these false positives,
it does provide biologists a reasonable set of potential tar-
get genes and a sense of the trustworthiness of the out-
come. By estimating FDR by permutations of the data,
SAM assumes that all null hypotheses are true; hence the
estimated FDR is biased upward. Storey and Tibshirani
tackled this problem by multiplying FDR by an estimate
of the proportion of true null hypotheses, π0. A detailed
description of the algorithm can be found in Storey and
Tibshirani [6]. Following their approach, the 18% false
discovery rate is lowered to about 13% by assuming that
not all hypotheses are null. Further recent comparisons of
multiple testing procedures are provided by Holland and
Cheung [19].
t-statistics vs. Welch statistics
We applied both t-statistics and Welch statistics. The
Welch statistics identified a set of genes having increased
expression in the patient group that were not detected by
t-statistics under the same stringency. One can argue that
the active genes have greater variability in gene expression
than inactive ones have [20]. Such a difference will be re-
flected in larger variances in the patient group relative to
the control group, a scenario more appropriate for Welch
statistics than t-statistics. In addition, subjects (patients)
in our analysis might be in different conditions. Some pa-
tients might have more tissue damage and/or more severe
pain than others. Further, the patient group is likely to be
inherently more heterogeneous with respect to the extent
of tissue damage and other relevant yet unmeasured at-
tributes. These considerations also argue for the appropri-
ateness of Welch statistics. Thomas, et al. also found that
Welch statistics conformed better than t-statistics to their
regression modeling approach used to discover differen-
tially expressed genes in a microarray setting where be-
tween-group heterogeneity was evident [10]. There are
drawbacks, however, to using the Welch statistics. Firstly,
they need to be calibrated, introducing distributional as-
sumptions. Secondly, and more importantly, there are sta-
bility and power concerns that pertain in small sample
settings [17].
Conclusion
The use of high-density microarray technology to identify
specific genes that are expressed differently under one or
more biological conditions is particularly relevant to drug
discovery and development. However, in the context of
microarray data analysis, multiple testing concerns are
forefront. In this study, we attacked the very important
problem of application of appropriate multiple testing
methods in identifying differential gene expression, and
in addition, we have provided a framework for future ex-
perimental research in brachial plexus injuries and pain
pathways. Simple statistical summaries, such as fold
change, t-statistics and Welch statistics, have been applied.
To further investigate some recently proposed multiple
testing schemes, we compared the performance of two ap-
proaches, SAM and Westfall and Young step down adjust-
ed p values, as applied to a microarray study of gene
expression in a brachial plexus injury. Our results showPage 8 of 11
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tion of a set of potentially interesting genes consistent
with prior knowledge of their function. In addition, SAM
readily quantitates the trade-offs between false discovery
rates and numbers of selected genes. On the other hand,
the Westfall and Young algorithm, by controlling FWER,
is highly conservative in this small sample setting. To the
extent that FWER provides appreciably more stringent se-
lection, attendant findings of significant differential gene
expression are more likely to be validated (by follow-up
experiment) than those deriving from FDR-controlling
methods. However, there has been recent recognition
[5,6,21] and our study also shows that FWER-control can
be unnecessarily stringent since falsely selecting a few
genes will not be a serious problem if the majority of dif-
ferentially expressed genes are chosen correctly. In addi-
tion to comparing multiple testing algorithms, we also
compared the performance of t-statistics and Welch statis-
tics. By taking into account the heterogeneous nature of
the patient group, Welch statistics identified a set of genes
having increased expression in the patient group, whereas
these genes were not selected by the t-statistics under the
same criteria.
Methods
Materials
Briefly, cervical avulsed human DRG tissues (n = 10) were
removed in the setting of a dorsal rhizotomy of lower cer-
vical (and upper thoracic in one case) nerve roots in pa-
tients with persistent pain syndromes after accidental
avulsion injuries. Details on obtaining, processing and
measuring the expression of total RNA in the human DRG
and control tissue samples are located elsewhere  [http://
itsa.ucsf.edu/~yxiao/Avulsion]. The control human DRG
sample was pooled from total RNA (n = 8; prepared by
Clontech) obtained from post-mortem tissues.  The pool
of n=8 was then run in triplicate (n=3). Total RNA was ex-
tracted from the tissue by Trizol (LifeTechnologies) extrac-
tion and polyA+ RNA was recovered by Oligotex mRNA
Spin Columns (Qiagen). Biotinylated cRNA targets were
prepared and hybridized to Affymetrix HU6800 oligonu-
cleotide arrays according to the manufacturer's protocol
(Affymetrix, Santa Clara, California).
Data analysis methods
Normalization
All data from patient and control samples were preproc-
essed (background subtraction, differential intensities)
using Affymetrix GeneChip software, and average differ-
ential intensity (ADI) was used for analysis. The average of
all ADI values of each chip was calculated and the mean
of average values of all chips was used as the target inten-
sity. The ADI value of each chip was normalized to be
equal to the target intensity. Since negative, zero, and very
small positive values (<20) of ADI most likely represent
noise instead of actual gene expression, all such values
were truncated at 20 resulting in 5,638 probe sets for anal-
ysis.
Graphical display
A Quantile-Quantile plot (Q-Q plot) was generated by
plotting the quantiles of t statistics of all genes against the
quantiles of a standard normal distribution. In addition
to examining the distribution of t statistics, we used this
plot to observe points that deviate markedly from the bulk
of the observations since they may represent difference in
means of the patient and control groups. Four scatter plots
were generated to study the features of large t statistics: t
statistics vs. average intensities, t statistics vs. t denomina-
tors, t statistics vs. t numerators, and t numerators vs. t de-
nominators.
Significance Analysis of Microarrays (SAM)
The SAM procedure described by Tusher et al. [3] based on
the t-statistic (under the assumption of equal variances
between the two groups) and the Welch statistic (under
the assumption of unequal variances between the two
groups) was modified as follows:
1. The relative difference in the expression d(i) for the ith
of k = 5638 probe sets was defined as,
 ; i = 1, 2, ..., k
where  and  are means of expression levels of
probe set i in the patient and control groups, respectively. 
For statistics,
  
and for Welch statistics, 
; 
where  and  are the variances of expression levels
for probe set i in the patient and control groups. The de-
termination of s0 is discussed in the Results section. For all
d(i) values, corresponding p values were calculated with
d(i) referenced to an appropriate t distribution.
2. All p values were ordered: p1 ≤ p2 ≤ ... ≤ pk.
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figuration, 286 being 13 choose 3) permutations were
conducted. For each permutation b, p values were calculat-
ed and ordered in the way of
 
4. Expected p values for all probe sets were calculated as
 , where i = 1, 2, ..., k.
5. For a fixed threshold ∆, a probe set was called "signifi-
cant" if its p value satisfied the criterion
 . 
The total number of "significant" probe sets was counted.
The pilargest among the "significant" probe set was de-
fined as the cutoff value.
6. For each permutation, all probe sets whose p values
were smaller than the cutoff value were found and were
called "falsely significant". The total number of these
probe sets was counted. The estimated number of "falsely
significant" probe sets was defined as the average of the
number of "falsely significant" probe sets from all permu-
tations. The false discovery rate (FDR) was computed as
the ratio of the estimated number of "falsely significant"
probe sets to the total number of "significant" probe sets.
7. FDR was computed with different values of threshold ∆.
Westfall and Young step-down adjusted p values
Both t-statistics and Welch statistics were used to compare
gene expression between the patient and control groups.
Our data were organized in a matrix in which each row
represents the expression of one gene for all subjects and
each column represents the expression of all genes for one
subject. The permutation algorithm developed by Westfall
and Young to obtain step-down adjusted p values was
then applied as follows. Note that the procedures were
modified when using Welch statistics. Instead of using the
Welch statistic to compute adjusted p values, we used un-
adjusted p values derived from Welch statistics and the ap-
propriate degrees of freedom. An exhaustive set of 285
permutations were conducted.
1. Compute the t statistic for each gene in the original da-
taset.
2. Order them: |tr1| ≥ |tr2| ≥ |tr3| ≥ ... ≥ |trk|.
3. Permute the 13 columns of the data matrix. The first 10
columns now represent the pseudo-patient group and the
other 3 columns represent the pseudo-control group.
4. Compute t statistics for all probe sets for the permuted
dataset:
 
5. Compute  
and
 , 
1 ≤ j ≤ k - 1, where rj is such that |tr1| ≥ |tr2| ≥ |tr3| ≥ ... ≥
|trk| for the original dataset.
6. Repeat 1–5 N (N = 286) times and calculate the adjust-
ed p values:
where I(•) is the indicator function setting to 1 if the con-
dition in parentheses is true and 0 if false. The monotonic-
ity was enforced as
 , for 2 ≤ j ≤ k.
Supplementary material
Supplementary material is located at [2]. This web page
includes our data analysis results and also further tissue
and patient information.
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